Title:
INHIBITORS OF CYCLIN-DEPENDENT KINASE (CDK) 12 AND/OR CDK13 AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/032561
Kind Code:
A1
Abstract:
Described herein are inhibitors of cyclin-dependent kinase (CDK) 12 and/or CDK13 (and pharmaceutical compositions comprising the inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with overexpression of CDK 12 and/or CDK13.
Inventors:
LU HONGFU (CN)
LIU YINGTAO (CN)
WU JIANPING (CN)
ZHENG MIN (CN)
REN FENG (CN)
LIU YINGTAO (CN)
WU JIANPING (CN)
ZHENG MIN (CN)
REN FENG (CN)
Application Number:
PCT/CN2023/111521
Publication Date:
February 15, 2024
Filing Date:
August 07, 2023
Export Citation:
Assignee:
INSILICO MEDICINE IP LTD (CN)
International Classes:
C07D403/14; A61K31/505; A61K31/519; A61P35/00; C07D471/12; C07D487/12
Domestic Patent References:
| WO2019213403A1 | 2019-11-07 | |||
| WO2023102184A1 | 2023-06-08 | |||
| WO2023091726A1 | 2023-05-25 |
Foreign References:
| CN114401955A | 2022-04-26 | |||
| CN112638373A | 2021-04-09 | |||
| CN102372717A | 2012-03-14 | |||
| CN115175899A | 2022-10-11 |
Attorney, Agent or Firm:
AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF:
Previous Patent: METHOD FOR OVER-ERASE REPAIR, AND STORAGE APPARATUS
Next Patent: COMMUNICATION METHOD AND APPARATUS
Next Patent: COMMUNICATION METHOD AND APPARATUS